Overview

Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if vitamin D supplementation changes the results of certain tests associated with inflammation in the body using an oral, synthetic form of vitamin D called paricalcitol.
Phase:
Phase 3
Details
Lead Sponsor:
Thomas Jefferson University
Collaborator:
Abbott
Treatments:
Ergocalciferols
Vitamin D
Vitamins